Neuropathological alterations in Alzheimer disease

Cited by (1,028)

Items 301–400 of 1,028

1. Polymicrobial Infections In Brain Tissue From Alzheimer’s Disease Patients
   Pisa, Diana, Alonso, Ruth, Fernández-Fernández, Ana M., Rábano, Alberto, Carrasco, Luis · 2017 · Scientific Reports
2. Genetics, Functions, and Clinical Impact of Presenilin-1 (PSEN1) Gene
   Jaya Bagaria, Eva Bagyinszky, Seong Soo A. An · 2022 · International Journal of Molecular Sciences
3. Glutaminyl Cyclase in Human Cortex: Correlation with (pGlu)-Amyloid-β Load and Cognitive Decline in Alzheimer's Disease
   Markus Morawski, Stephan Schilling, Moritz Kreuzberger, Alexander Waniek, Carsten Jäger, Birgit Maria Koch, Holger Cynis, Astrid Kehlen, Thomas Arendt, Maike Hartlage‐Rübsamen et al. · 2014 · Journal of Alzheimer s Disease
4. Olfactory Receptors in Non-Chemosensory Organs: The Nervous System in Health and Disease
   Isidró Ferrer, Paula Garcia‐Esparcia, Margarita Carmona, Eva Carro, Eleonora Aronica, Gábor Géza Kovács, Alice Grison, Stefano Gustincich · 2016 · Frontiers in Aging Neuroscience
5. Optogenetic stimulation of dentate gyrus engrams restores memory in Alzheimer's disease mice
   Jennifer N. Perusini, Stephanie A. Cajigas, Omid Cohensedgh, Sean C. Lim, Ina P. Pavlova, Zoe R. Donaldson, Christine Ann Denny · 2017 · Hippocampus
6. Aβ42 oligomers trigger synaptic loss through CAMKK2-AMPK-dependent effectors coordinating mitochondrial fission and mitophagy
   Annie Lee, Chandana Kondapalli, Daniel M. Virga, Tommy L. Lewis, So Yeon Koo, Archana Ashok, Georges Mairet‐Coello, Sébastien Herzig, Marc Foretz, Benoı̂t Viollet et al. · 2022 · Nature Communications
7. Diet and Alzheimer's dementia – Nutritional approach to modulate inflammation
   Katarzyna Szczechowiak, Breno Satler Diniz, Jerzy Leszek · 2019 · Pharmacology Biochemistry and Behavior
8. Zebrafish as a model for investigating developmental lead (Pb) neurotoxicity as a risk factor in adult neurodegenerative disease: A mini-review
   Jinyoung Lee, Jennifer L. Freeman · 2014 · NeuroToxicology
9. High resolution dissection of reactive glial nets in Alzheimer’s disease
   Bouvier, David S., Jones, Emma V., Quesseveur, Gaël, Davoli, Maria Antonietta, A. Ferreira, Tiago, Quirion, Rémi, Mechawar, Naguib, Murai, Keith K. · 2016 · Scientific Reports
10. Quantitative sodium MR imaging: A review of its evolving role in medicine
    Keith R. Thulborn · 2016 · NeuroImage
11. Traffic-related air pollution impact on mouse brain accelerates myelin and neuritic aging changes with specificity for CA1 neurons
    Nicholas C. Woodward, Payam Pakbin, Arian A. Saffari, Farimah Shirmohammadi, Amin Haghani, Constantinos Sioutas, Mafalda Cacciottolo, Todd E. Morgan, Caleb E. Finch · 2017 · Neurobiology of Aging
12. The role of neutrophil granule proteins in neuroinflammation and Alzheimer’s disease
    Amanda J. Stock, Anne Kasus‐Jacobi, Heloise Anne Pereira · 2018 · Journal of Neuroinflammation
13. DNA methylation signature of human hippocampus in Alzheimer’s disease is linked to neurogenesis
    M. Altuna, Amaya Urdánoz-Casado, Javier Sánchez-Ruiz de Gordoa, M. Zelaya, A. Labarga, Julie M. J. Lepesant, Miren Roldan, I. Blanco-Luquin, Álvaro Perdones, R. Larumbe et al. · 2019 · Clinical Epigenetics
14. CryoET of β-amyloid and tau within postmortem Alzheimer’s disease brain
    Madeleine A. G. Gilbert, Nayab Fatima, Joshua Jenkins, Thomas J. O’Sullivan, Andreas Schertel, Yehuda Halfon, Martin Wilkinson, Tjado H. J. Morrema, Mirjam Geibel, Randy J. Read et al. · 2024 · Nature
15. Atomic force microscopy to study molecular mechanisms of amyloid fibril formation and toxicity in Alzheimer’s disease
    Elizabeth Drolle, Francis T. Hane, Brenda Yasie Lee, Zoya Leonenko · 2014 · Drug Metabolism Reviews
16. An EEG-fNIRS hybridization technique in the four-class classification of alzheimer’s disease
    Pietro Antonio Cicalese, Rihui Li, Mohammad Badri Ahmadi, Chushan Wang, Joseph Thachil Francis, Sudhakar Selvaraj, Paul Ernest Schulz, Yingchun Zhang · 2020 · Journal of Neuroscience Methods
17. Human neural stem cell-derived extracellular vesicles mitigate hallmarks of Alzheimer’s disease
    Lauren A. Apodaca, Al Anoud D. Baddour, Camilo Garcia, Leila Alikhani, Erich Giedzinski, Ning Ru, Anshu Agrawal, Munjal M. Acharya, Janet E. Baulch · 2021 · Alzheimer s Research & Therapy
18. TGF-β1 signalling in Alzheimer’s pathology and cytoskeletal reorganization: a specialized Tau perspective
    Mahima Kapoor, Subashchandrabose Chinnathambi · 2023 · Journal of Neuroinflammation
19. Neurodegeneration-Associated Protein Fragments as Short-Lived Substrates of the N-End Rule Pathway
    Christopher S. Brower, Konstantin I. Piatkov, Alexander J. Varshavsky · 2013 · Molecular Cell
20. Exploring the Effect of Phyllanthus emblica L. on Cognitive Performance, Brain Antioxidant Markers and Acetylcholinesterase Activity in Rats: Promising Natural Gift for the Mitigation of Alzheimer's Disease
    Md. Sahab Uddin, Abdullah Al Mamun, Md. Sarwar Hossain, Farjana Akter, Mohammed Ashraful Iqbal, Md. Asaduzzaman · 2016 · Annals of Neurosciences
21. Role of phosphatidylcholine‐DHA in preventing APOE4‐associated Alzheimer's disease
    Rhonda P. Patrick · 2018 · The FASEB Journal
22. Comparative profiling of the synaptic proteome from Alzheimer’s disease patients with focus on the APOE genotype
    Raphael Hesse, Maica Llavero Hurtado, Rosemary J. Jackson, Samantha L. Eaton, Abigail G. Herrmann, Martí Colom‐Cadena, Makis Tzioras, Declan King, Jamie L. Rose, Jane Tulloch et al. · 2019 · Acta Neuropathologica Communications
23. Dopamine: an immune transmitter
    Sarah Thomas Broome, Krystal Louangaphay, Kevin A. Keay, Gian Marco Leggio, Giuseppe Musumeci, Alessandro Castorina · 2020 · Neural Regeneration Research
24. Brain Shape Changes Associated With Cerebral Atrophy in Healthy Aging and Alzheimer’s Disease
    Yana Blinkouskaya, Johannes Weickenmeier · 2021 · Frontiers in Mechanical Engineering
25. Amyloid-β accumulation in human astrocytes induces mitochondrial disruption and changed energy metabolism
    Marlena Zyśk, Chiara Beretta, Luana Naia, Abdulkhalek Dakhel, Linnéa Påvénius, Hjalmar Brismar, Maria Lindskog, Maria Ankarcrona, Anna Erlandsson · 2023 · Journal of Neuroinflammation
26. [F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging
    Marquié, Marta, Siao Tick Chong, Michael, Antón-Fernández, Alejandro, Verwer, Eline E., Sáez-Calveras, Nil, Meltzer, Avery C., Ramanan, Prianca, Amaral, Ana C., Gonzalez, Jose, Normandin, Marc D. et al. · 2017 · Acta Neuropathologica
27. Natural Products in Alzheimer’s Disease Therapy: Would Old Therapeutic Approaches Fix the Broken Promise of Modern Medicines?
    Solomon Habtemariam · 2019 · Molecules
28. Identification of the Early Stage of Alzheimer's Disease Using Structural MRI and Resting-State fMRI
    Seyed Hani Hojjati, Ata Ebrahimzadeh, Abbas Babajani-feremi A · 2019 · Frontiers in Neurology
29. Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview
    Libro, Rosaliana, Giacoppo, Sabrina, Soundara Rajan, Thangavelu, Bramanti, Placido, Mazzon, Emanuela · 2016 · Molecules
30. The role of amyloid β in the pathogenesis of Alzheimer's disease
    Barnabas James Gilbert · 2013 · Journal of Clinical Pathology
31. Reactive Oxygen Species, Redox Signaling and Neuroinflammation in Alzheimer's Disease: The NF-κB Connection
    Upinder Kaur, Priyanjalee Banerjee, Aritri Bir, Maitrayee Sardar Sinha, Atanu Biswas, Sasanka Chakrabarti · 2015 · Current Topics in Medicinal Chemistry
32. Nucleic acid drug vectors for diagnosis and treatment of brain diseases
    Zhiguo Lü, Jie Shen, H. J. Yang, Jingwen Wang, Ruichen Zhao, Tian-Lu Zhang, Jing Ru Guo, Xin Zhang · 2023 · Signal Transduction and Targeted Therapy
33. A Role for P-Glycoprotein in Clearance of Alzheimer Amyloid ? -Peptide from the Brain
    Wang, Wei, M. Bodles-Brakhop, Angela, W. Barger, Steven · 2016 · Current Alzheimer Research
34. Health benefits of methylxanthines in neurodegenerative diseases
    Ainhoa Oñatibia‐Astibia, Rafael Franco, Eva Martínez‐Pinilla · 2017 · Molecular Nutrition & Food Research
35. Extracellular Vesicle Biology in Alzheimer’s Disease and Related Tauopathy
    Annina M. DeLeo, Tsuneya Ikezu · 2017 · Journal of Neuroimmune Pharmacology
36. Vitamin D and Neurodegenerative Diseases
    Weixia Wang, Yijin Li, Xianfang Meng · 2022 · Heliyon
37. Suppression of NADPH oxidase- and mitochondrion-derived superoxide by Notoginsenoside R1 protects against cerebral ischemia–reperfusion injury through estrogen receptor-dependent activation of Akt/Nrf2 pathways
    Xiangbao Meng, M. Wang, X. Wang, G. Sun, J. Ye, Haiyang Xu, Xinyan Sun · 2014 · Free Radical Research
38. Confounding Parameters in Preclinical Assessment of Blood–Brain Barrier Permeation: An Overview With Emphasis on Species Differences and Effect of Disease States
    Anand K. Deo, Frank‐Peter Theil, Jean-Marie Nicolas · 2012 · Molecular Pharmaceutics
39. Amyloid-β induces lipid droplet-mediated microglial dysfunction via the enzyme DGAT2 in Alzheimer’s disease
    Prakash, Priya, Manchanda, Palak, Paouri, Evi, Bisht, Kanchan, Sharma, Kaushik, Rajpoot, Jitika, Wendt, Victoria, Hossain, Ahad, Wijewardhane, Prageeth R., Randolph, Caitlin E. et al. · 2025 · Immunity
40. Translational research on reserve against neurodegenerative disease: consensus report of the International Conference on Cognitive Reserve in the Dementias and the Alzheimer’s Association Reserve, Resilience and Protective Factors Professional Interest Area working groups
    Robert Perneczky, Gerd Kempermann, Amos D. Korczyn, Fiona E. Matthews, M. Arfan Ikram, Nikolaos Scarmeas, Gaël Chételat, Yaakov Stern, Michael Ewers · 2019 · BMC Medicine
41. The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer′s Disease (AD)
    Barbara Mroczko, Magdalena Groblewska, Ala Litman‐Zawadzka · 2019 · International Journal of Molecular Sciences
42. Alterations in the Gut-Microbial-Inflammasome-Brain Axis in a Mouse Model of Alzheimer’s Disease
    Pradeep K. Shukla, David F. Delotterie, Jianfeng Xiao, Joseph F. Pierre, Radhakrishna Rao, Michael P. McDonald, Mohammad Moshahid Khan · 2021 · Cells
43. Adult hippocampal neurogenesis and its impairment in Alzheimer’s disease
    Thomas A. Kim, M. Syty, Kaitlyn Wu, Shaoyu Ge · 2022 · Zoological Research
44. Evidence for Alzheimer’s disease-linked synapse loss and compensation in mouse and human hippocampal CA1 pyramidal neurons
    Krystina M. Neuman, Elizabeth Molina-Campos, Timothy F. Musial, Andrea L. Price, Kwang-Jin Oh, Malerie L. Wolke, Eric W. Buss, Stephen W. Scheff, Elliott Jay Mufson, Daniel A. Nicholson · 2014 · Brain Structure and Function
45. A critical review of chronic traumatic encephalopathy
    Iverson, Grant L., Gardner, Andrew J., McCrory, Paul, Zafonte, Ross, Castellani, Rudy J. · 2015 · Neuroscience & Biobehavioral Reviews
46. Is Alzheimer's disease related to metabolic syndrome? A Wnt signaling conundrum
    Juvenal A. Ríos, Pedro Cisternas, Marco A. Arrese, Salesa Barja Y., Nibaldo C. Inestrosa · 2014 · Progress in Neurobiology
47. Identification of Fungal Species in Brain Tissue from Alzheimer’s Disease by Next-Generation Sequencing
    Ruth Alonso, Diana Pisa, Begoña Aguado, Luis Carrasco · 2017 · Journal of Alzheimer s Disease
48. In Vivo Mitochondrial and Glycolytic Impairments in Patients with Alzheimer Disease
    Terada, Tatsuhiro, Obi, Tomokazu, Bunai, Tomoyasu, Matsudaira, Takashi, Yoshikawa, Etsuji, Ando, Ichiro, Futatsubashi, Masami, Tsukada, Hideo, Ouchi, Yasuomi · 2020 · Neurology
49. Age‐related calcium dysregulation linked with tau pathology and impaired cognition in non‐human primates
    Dibyadeep Datta, Shannon N. Leslie, Min Wang, Yury M. Morozov, Shengtao Yang, SueAnn Mentone, Caroline J. Zeiss, Alvaro Duque, PASKO T. RAKIC, Tamás L. Horváth et al. · 2021 · Alzheimer s & Dementia
50. Inflammatory Cascade in Alzheimer’s Disease Pathogenesis: A Review of Experimental Findings
    Jade de Oliveira, Ewa Kucharska, Michelle Lima Garcez, Matheus Scarpatto Rodrigues, João Quevedo, Inés Moreno‐González, Josiane Budni · 2021 · Cells
51. ABCB1 and ABCG2 Regulation at the Blood-Brain Barrier: Potential New Targets to Improve Brain Drug Delivery
    J Schulz, Anika M. S. Hartz, Björn Bauer · 2023 · Pharmacological Reviews
52. Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification
    Nicholas J. Izzo, Carla M. Yuede, Kelsie Mozzoni, Colleen S. Limegrover, Courtney Rehak, Raymond Yurko, Lora Waybright, Gary C. Look, Gilbert M. Rishton, Hank Safferstein et al. · 2021 · Alzheimer s & Dementia
53. Synaptic degeneration and neurogranin in the pathophysiology of Alzheimer’s disease
    Simone Lista, Harald Juergen Hampel · 2016 · Expert Review of Neurotherapeutics
54. Targeting S100B Protein as a Surrogate Biomarker and its Role in Various Neurological Disorders
    Urvashi Langeh, Shamsher Singh · 2020 · Current Neuropharmacology
55. Microbial Infections Are a Risk Factor for Neurodegenerative Diseases
    Sarah K. Lotz, Britanie M. Blackhurst, Katie L. Reagin, Kristen E. Funk · 2021 · Frontiers in Cellular Neuroscience
56. Identification of Differentially Expressed Genes through Integrated Study of Alzheimer’s Disease Affected Brain Regions
    Nisha Puthiyedth, Carlos Riveros, Regina Esther Berretta, Pablo Moscato · 2016 · PLoS ONE
57. Current Understanding of the Physiopathology, Diagnosis and Therapeutic Approach to Alzheimer’s Disease
    García-Morales, Victoria, González-Acedo, Anabel, Melguizo-Rodríguez, Lucía, Pardo-Moreno, Teresa, Costela-Ruiz, Víctor Javier, Montiel-Troya, María, Ramos-Rodríguez, Juan José · 2021 · Biomedicines
58. A tool for mapping microglial morphology, morphOMICs, reveals brain-region and sex-dependent phenotypes
    Colombo, Gloria, Cubero, Ryan John A., Kanari, Lida, Venturino, Alessandro, Schulz, Rouven, Scolamiero, Martina, Agerberg, Jens, Mathys, Hansruedi, Tsai, Li-Huei, Chachólski, Wojciech et al. · 2022 · Nature Neuroscience
59. A protein homeostasis signature in healthy brains recapitulates tissue vulnerability to Alzheimer’s disease
    Rosie Freer, Pietro Sormanni, Giulia Vecchi, Prajwal Ciryam, Christopher Martin Dobson, Michele Vendruscolo · 2016 · Science Advances
60. Mangiferin and Morin Attenuate Oxidative Stress, Mitochondrial Dysfunction, and Neurocytotoxicity, Induced by Amyloid Beta Oligomers
    Elena M Alberdi, María Victoria Sánchez‐Gómez, Asier Ruiz, Fabio Cavaliere, Carolina Ortiz-Sanz, Tania Quintela‐López, Estibaliz Capetillo‐Zarate, Santiago Solé‐Domènech, Carlos Matute · 2018 · Oxidative Medicine and Cellular Longevity
61. Comparison of ELISA- and SIMOA-based quantification of plasma Aβ ratios for early detection of cerebral amyloidosis
    Steffi De Meyer, Jolien M. Schaeverbeke, Inge M.W. Verberk, Benjamin Gille, Maxim De Schaepdryver, Emma Susanne Luckett, Silvy Gabel, Rose Bruffaerts, Kimberley Mauroo, Elisabeth H. Thijssen et al. · 2020 · Alzheimer s Research & Therapy
62. Protein Expression of Angiotensin-Converting Enzyme 2 (ACE2) is Upregulated in Brains with Alzheimer’s Disease
    Qiyue Ding, Nataliia V. Shults, Sergiy G. Gychka, Brent T. Harris, Yuichiro Suzuki · 2021 · International Journal of Molecular Sciences
63. Astrocyte–neuron interplay is critical for Alzheimer's disease pathogenesis and is rescued by TRPA1 channel blockade
    Adrien Paumier, Sylvie Boisseau, Muriel R. Jacquier‐Sarlin, Karin Pernet‐Gallay, Alain Buisson, Mireille Albrieux · 2021 · Brain
64. Attenuation of Aβ25-35-induced parallel autophagic and apoptotic cell death by gypenoside XVII through the estrogen receptor-dependent activation of Nrf2/ARE pathways.
    Xiangbao Meng, Min Wang, Gui-Bo Sun, Jing-Xue Ye, Yanhui Zhou, Xi Dong, Tingting Wang, S. Lu, Xiao-Bo Sun · 2014 · Toxicology and Applied Pharmacology
65. Plaque-associated local toxicity increases over the clinical course of Alzheimer disease
    Serrano-Pozo, Alberto, Betensky, Rebecca A., Frosch, Matthew P., Hyman, Bradley T. · 2016 · The American Journal of Pathology
66. Changes in the detergent‐insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression
    Hales, Chadwick M., Dammer, Eric B., Deng, Qiudong, Duong, Duc M., Gearing, Marla, Troncoso, Juan C., Thambisetty, Madhav, Lah, James J., Shulman, Joshua M., Levey, Allan I. et al. · 2016 · PROTEOMICS
67. Neuropathology of Autosomal Dominant Alzheimer Disease in the National Alzheimer Coordinating Center Database
    Ringman, John M., Monsell, Sarah, Ng, Denise W., Zhou, Yan, Nguyen, Andy, Coppola, Giovanni, Van Berlo, Victoria, Mendez, Mario F., Tung, Spencer, Weintraub, Sandra et al. · 2016 · Journal of Neuropathology & Experimental Neurology
68. The role of GPCRs in neurodegenerative diseases: avenues for therapeutic intervention
    Yunhong Huang, Nicholas Todd, Amantha Thathiah · 2017 · Current Opinion in Pharmacology
69. Reinstating plasticity and memory in a tauopathy mouse model with an acetyltransferase activator
    Snehajyoti Chatterjee, Raphaelle Cassel, Anne Schneider‐Anthony, Karine Mérienne, Brigitte Cosquer, Laura Tzeplaeff, Sarmistha Halder Sinha, Manoj Kumar, Piyush Chaturbedy, Muthusamy Eswaramoorthy et al. · 2018 · EMBO Molecular Medicine
70. A Meta-Analysis of Alzheimer’s Disease Brain Transcriptomic Data
    Hamel Patel, Richard Dobson, Stephen J Newhouse · 2019 · Journal of Alzheimer s Disease
71. Alzheimer’s disease: A clinical perspective and future nonhuman primate research opportunities
    Rafi U. Haque, Allan I. Levey · 2019 · Proceedings of the National Academy of Sciences
72. Eating Behavior in Aging and Dementia: The Need for a Comprehensive Assessment
    Silvia Fostinelli, Ramona Silvana De Amicis, Alessandro Leone, Valentina Giustizieri, Giuliano Gb. Binetti, Simona Bertoli, Alberto Battezzati, Stefano Francesco Cappa · 2020 · Frontiers in Nutrition
73. G-protein coupled receptor, PI3K and Rho signaling pathways regulate the cascades of Tau and amyloid-β in Alzheimer’s disease
    Desale, Smita Eknath, Chidambaram, Hariharakrishnan, Chinnathambi, Subashchandrabose · 2021 · Molecular Biomedicine
74. Potential and Limits of Cannabinoids in Alzheimer’s Disease Therapy
    Giulia Abate, Daniela Letizia Uberti, Simone Tambaro · 2021 · Biology
75. Postsynaptic Receptors for Amyloid-β Oligomers as Mediators of Neuronal Damage in Alzheimer’s Disease
    Margarita C. Dinamarca, Juvenal A. Ríos, Nibaldo C. Inestrosa · 2012 · Frontiers in Physiology
76. Normalizing the gene dosage of Dyrk1A in a mouse model of down syndrome rescues several Alzheimer’s disease phenotypes
    García-Cerro, Susana, Rueda, Noemí, Vidal, Verónica, Lantigua, Sara, Martínez-Cué, Carmen · 2017 · Neurobiology of Disease
77. An Update of Animal Models of Alzheimer Disease with a Reevaluation of Plaque Depositions
    Jung Eun Lee, Pyung‐Lim Han · 2013 · Experimental Neurobiology
78. Therapeutic impact of grape leaves polyphenols on certain biochemical and neurological markers in AlCl3-induced Alzheimer’s disease
    Ibrahim H. Borai, Magda K. Ezz, Maha Z. Rizk, Hanan Farouk Aly, Mahmoud El-Sherbiny, Azza Abdelmageed Matloub, Ghadha Ibrahim Fouad · 2017 · Biomedicine & Pharmacotherapy
79. Plumbagin ameliorates memory dysfunction in streptozotocin induced Alzheimer’s disease via activation of Nrf2/ARE pathway and inhibition of β-secretase
    Kartik Tularam Nakhate, Ashish P. Bharne, Vinay Sagar Verma, Deepali N. Aru, Dadasaheb M. Kokare · 2018 · Biomedicine & Pharmacotherapy
80. Toxoplasma gondii alters NMDAR signaling and induces signs of Alzheimer’s disease in wild-type, C57BL/6 mice
    Luisa Torres, Sudie-Ann Robinson, Do-Geun Kim, Angela Yan, Thomas A. Cleland, Margaret S. Bynoe · 2018 · Journal of Neuroinflammation
81. Cell Cycle Deficits in Neurodegenerative Disorders: Uncovering Molecular Mechanisms to Drive Innovative Therapeutic Development
    Chitra Joseph, Abubakar Siddiq Mangani, Veer Bala Gupta, Nitin Chitranshi, Ting Shen, Yogita Dheer, Devaraj KB, Mehdi Mirzaei, Yuyi You, Stuart L. Graham et al. · 2020 · Aging and Disease
82. Interaction of Tau with the chemokine receptor, CX3CR1 and its effect on microglial activation, migration and proliferation
    Hariharakrishnan Chidambaram, Rashmi Ranjan Das, Subashchandrabose Chinnathambi · 2020 · Cell & Bioscience
83. Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
    Mroczko, Barbara, Groblewska, Magdalena, Litman-Zawadzka, Ala, Kornhuber, Johannes, Lewczuk, Piotr · 2018 · International Journal of Molecular Sciences
84. Recent advances in lipidomics for disease research
    Yang Li, Min Li, Yabing Shan, Sensen Shen, Yu Bai, Huwei Liu · 2015 · Journal of Separation Science
85. Tau in neurodegenerative diseases: molecular mechanisms, biomarkers, and therapeutic strategies
    Xingyu Zhang, Jiangyu Wang, Zhentao Zhang, Keqiang Ye · 2024 · Translational Neurodegeneration
86. Network Disruption and Cerebrospinal Fluid Amyloid-Beta and Phospho-Tau Levels in Mild Cognitive Impairment
    Leonides Canuet, Sandra Angelica Pusil, María Eugenia López, Ricardo Bajo, José A. Pineda‐Pardo, Pablo Cuesta, Gerardo Gálvez, J.M. Gaztelu, Daniel Lourido, Guillermo García‐Ribas et al. · 2015 · Journal of Neuroscience
87. Tau missorting and spastin-induced microtubule disruption in neurodegeneration: Alzheimer Disease and Hereditary Spastic Paraplegia
    Hans Zempel, Eva‐Maria Mandelkow · 2015 · Molecular Neurodegeneration
88. Photosensitizing materials and platforms for light-triggered modulation of Alzheimer's β-amyloid self-assembly
    Byung Il Lee, You Jung Chung, Chan Beum Park · 2018 · Biomaterials
89. Frontiers in Probing Alzheimer’s Disease Biomarkers with Fluorescent Small Molecules
    Yong Woong Jun, Seo Won Cho, Junyang Jung, Youngbuhm Huh, Young Soo Kim, Dokyoung Kim, Kyo Han Ahn · 2019 · ACS Central Science
90. Recent Developments along the Analytical Process for Metabolomics Workflows
    Carolina González-Riaño, Danuta Dudzik, Antonia Garcı́a, Alberto Gil-de-la-Fuente, Ana Gradillas, Joanna Godzień, Ángeles López‐Gonzálvez, Fernanda Rey-Stolle, David Rojo, Francisco Javier Rupérez et al. · 2019 · Analytical Chemistry
91. Lipid-based nanoformulations in the treatment of neurological disorders
    Faheem Hyder Pottoo, Shrestha Sharma, Md. Noushad Javed, Md. Abul Barkat, Harshita, Md Sabir Alam, Mohd. Javed Naim, Ozair Alam, Mohammad Azam Ansari, George Emilio Barreto et al. · 2020 · Drug Metabolism Reviews
92. Hippocampal proteomics defines pathways associated with memory decline and resilience in normal aging and Alzheimer’s disease mouse models
    Sarah M. Neuner, Lynda A. Wilmott, Brian Robert Hoffmann, Khyobeni Mozhui, Catherine Cook Kaczorowski · 2016 · Behavioural Brain Research
93. Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer’s disease
    Maria Luisa Moro, Andrew Stephen Phillips, Katie Gaimster, Christian Paul, Amritpal K. Mudher, James A. R. Nicoll, Delphine Boche · 2018 · Acta Neuropathologica Communications
94. Alzheimer's disease pathology in the neocortex and hippocampus of the western lowland gorilla (<i>Gorilla gorilla gorilla</i>)
    Perez, Sylvia E., Raghanti, Mary Ann, Hof, Patrick R., Kramer, Lynn, Ikonomovic, Milos D., Lacor, Pascale N., Erwin, Joseph M., Sherwood, Chet C., Mufson, Elliott J. · 2013 · Journal of Comparative Neurology
95. Tau-mediated synaptic damage in Alzheimer’s disease
    Santosh Jadhav, Veronika Cubinkova, Ivana Zimova, Veronika Brezováková, Aladár Maďari, Viera Cigánková, Norbert Žilka · 2015 · Translational Neuroscience
96. Tau Pathology Distribution in Alzheimer's disease Corresponds Differentially to Cognition-Relevant Functional Brain Networks
    Oskar Hansson, Michel J. Grothe, Tor Olof Strandberg, Tomas G. Ohlsson, Douglas Hägerström, Jonas Jögi, Ruben A Smith, Michael Schöll · 2017 · Frontiers in Neuroscience
97. Pilot study of transcranial photobiomodulation of lymphatic clearance of beta-amyloid from the mouse brain: breakthrough strategies for non-pharmacologic therapy of Alzheimer’s disease
    Ekaterina M. Zinchenko, Никита Александрович Наволокин, Alexander A. Shirokov, Boris N. Khlebtsov, Alexander I. Dubrovsky, Elena I. Saranceva, Arkady Sergeevich Abdurashitov, Alexander P. Khorovodov, Andrey V. Terskov, Мамедова Айсель Тофик-Кызы et al. · 2019 · Biomedical Optics Express
98. Chronic oral administration of adipoRon reverses cognitive impairments and ameliorates neuropathology in an Alzheimer’s disease mouse model
    Roy Chun-Laam Ng, Min Jian, Oscar Ka-Fai Ma, Myriam Bunting, Jason Kwan, Guang-Jie Zhou, Senthilkumar Krishnamoorthi, Ashok Iyaswamy, Ping‐Kei Chan, Min Li et al. · 2020 · Molecular Psychiatry
99. Biosensors for detection of Tau protein as an Alzheimer's disease marker
    Mehrdad Ameri, Zahra Shabaninejad, Ahmad Movahedpour, Amirhossein Sahebkar, Soheila Mohammadi, Saereh Hosseindoost, Mohammad Saeid Ebrahimi, Amir Savardashtaki, Mohammad Karimipour, Hamed Mirzaei · 2020 · International Journal of Biological Macromolecules
100. Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer’s Disease Patients Measured Using [18F] THK-5351
     Samuel Neal Lockhart, Suzanne L. Baker, Nobuyuki Okamura, Katsutoshi Furukawa, Aiko Ishiki, Shozo Furumoto, Manabu Tashiro, Kazuhiko Yanai, Hiroyuki Arai, Yukitsuka Kudo et al. · 2016 · PLoS ONE